GE HealthCare Technologies Inc. $GEHC Shares Acquired by Prospera Financial Services Inc

Prospera Financial Services Inc boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 198.7% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 14,167 shares of the company’s stock after purchasing an additional 9,424 shares during the period. Prospera Financial Services Inc’s holdings in GE HealthCare Technologies were worth $1,050,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. N.E.W. Advisory Services LLC bought a new stake in shares of GE HealthCare Technologies in the first quarter worth $25,000. Bogart Wealth LLC grew its holdings in GE HealthCare Technologies by 260.0% during the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after acquiring an additional 247 shares in the last quarter. Gladwyn Financial Advisors Inc. bought a new stake in shares of GE HealthCare Technologies in the 2nd quarter worth about $34,000. Game Plan Financial Advisors LLC increased its position in shares of GE HealthCare Technologies by 295.3% in the 2nd quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock worth $37,000 after purchasing an additional 375 shares during the last quarter. Finally, Zions Bancorporation National Association UT acquired a new stake in shares of GE HealthCare Technologies in the 1st quarter valued at about $42,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Up 2.1%

Shares of GE HealthCare Technologies stock opened at $74.98 on Thursday. The stock has a market capitalization of $34.15 billion, a price-to-earnings ratio of 15.49, a PEG ratio of 2.76 and a beta of 1.13. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. The business’s 50 day simple moving average is $75.20 and its 200-day simple moving average is $73.65.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $5.07 billion. During the same period in the prior year, the business earned $1.14 EPS. The firm’s revenue was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.89%.

Analyst Upgrades and Downgrades

A number of research firms recently commented on GEHC. Evercore ISI lifted their price target on GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Morgan Stanley increased their target price on GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a report on Thursday, October 30th. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Tuesday. BTIG Research set a $87.00 price target on GE HealthCare Technologies in a research report on Wednesday, October 29th. Finally, Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $93.00 to $83.00 in a research note on Tuesday, October 7th. Six investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $86.10.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.